News & Announcements
-
IB and Prism Secure First Installation
/**/ RNS Number : 8964S IQ-AI Limited 10 January 2025 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics and Prism Clinical Imaging Secure First Installation The combined technologies will enhance neurosurgical planning and treatment strategies Imaging Biometrics (IB), a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), is pleased
-
Imaging Biometrics Expands Distribution
/**/ RNS Number : 8473M IQ-AI Limited 20 November 2024 November 20, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Expands Distribution Imaging Biometrics (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI) has renewed its distribution agreement with GE HealthCare. This agreement aims to expand the distribution
-
Board Changes
/**/ RNS Number : 8206M IQ-AI Limited 19 November 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Board Changes IQ-AI Appoints Renowned Brain Tumor Champion to Board of Directors IQ-AI Ltd (LSE: IQAI) is pleased to announce the appointment of Dr. Al Musella, MD, as a Non-Execuitve Director. Dr. Musella brings
-
New Patent Application and Trading Update
/**/ RNS Number : 8681K IQ-AI Limited 05 November 2024 November 5, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) New Patent Application, Trading Update and Commencement of discussions with potential phase 2 partners IQ-AI (LSE: IQAI) Imaging Biometrics (“IB”) has filed a provisional patent application with the United States Patent and Trademark
-
Holding(s) in Company
/**/ RNS Number : 2550I IQ-AI Limited 15 October 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which